1. Home
  2. RDNT vs LEGN Comparison

RDNT vs LEGN Comparison

Compare RDNT & LEGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo RadNet Inc.

RDNT

RadNet Inc.

HOLD

Current Price

$77.71

Market Cap

5.7B

Sector

Health Care

ML Signal

HOLD

Logo Legend Biotech Corporation

LEGN

Legend Biotech Corporation

HOLD

Current Price

$21.07

Market Cap

5.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RDNT
LEGN
Founded
1985
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.7B
5.9B
IPO Year
1986
2020

Fundamental Metrics

Financial Performance
Metric
RDNT
LEGN
Price
$77.71
$21.07
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
13
Target Price
$83.60
$69.58
AVG Volume (30 Days)
1.0M
2.5M
Earning Date
11-09-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,969,599,000.00
$909,045,000.00
Revenue This Year
$11.77
$68.52
Revenue Next Year
$10.76
$48.63
P/E Ratio
N/A
N/A
Revenue Growth
11.09
74.75
52 Week Low
$45.00
$20.26
52 Week High
$85.84
$45.30

Technical Indicators

Market Signals
Indicator
RDNT
LEGN
Relative Strength Index (RSI) 55.94 31.83
Support Level $70.31 $21.19
Resistance Level $73.52 $22.07
Average True Range (ATR) 3.00 0.77
MACD 0.36 0.11
Stochastic Oscillator 92.67 25.71

Price Performance

Historical Comparison
RDNT
LEGN

About RDNT RadNet Inc.

RadNet Inc is a national provider of diagnostic imaging services that operates in two business segments: Imaging Center segment and Digital Health segment. The Imaging Center segment provides physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders. Services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), and fluoroscopy. The Digital Health segment develops and deploys clinical applications to enhance the interpretation of medical images and improve patient outcomes with an emphasis on brain, breast, prostate, and pulmonary diagnostics.

About LEGN Legend Biotech Corporation

Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.

Share on Social Networks: